WEDNESDAY, Sept. 18, 2024 -- For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitor (SGLT2i) use is associated with reduced...

MONDAY, Sept. 16, 2024 -- For patients undergoing treatment for certain types of cancer, artificial intelligence (AI) can use electrocardiographic...

Novartis announced that the US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor (AI)...

MONDAY, Sept. 9, 2024 -- Cancer diagnosis is associated with an increased risk for psychological illness and cardiovascular disease among...

WEDNESDAY, Sept. 18, 2024 -- Habitual coffee or caffeine intake is associated with a lower risk for new-onset cardiometabolic multimorbidity (CM),...

THURSDAY, Sept. 5, 2024 -- World Trade Center (WTC) exposure is associated with increased DNA methylation, which may contribute to breast cancer,...

FRIDAY, Sept. 6, 2024 -- The risk for lung cancer is high in patients with rheumatoid arthritis (RA) and pulmonary complications, according to a study...

FRIDAY, Sept. 13, 2024 -- Smoking cessation is associated with a reduced risk for atrial fibrillation (AF), according to a study published online...

TUESDAY, Sept. 17, 2024 -- A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with...

THURSDAY, Sept. 12, 2024 -- The overall second primary malignancy (SPM) point estimate was 5.8 percent for patients receiving chimeric antigen...